Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension (2014)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00210-014-0970-8
- Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR) (APLICAÇÕES TERAPÊUTICAS); ENDOTÉLIO VASCULAR (ENZIMOLOGIA;EFEITOS DE DROGAS); HIPERTENSÃO
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2014
- Source:
- Título do periódico: Naunyn-Schmiedeberg's Archives of Pharmacology
- ISSN: 0028-1298
- Volume/Número/Paginação/Ano: v. 387, n. 6, p. 591-598, 2014
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MONTENEGRO, Marcelo F. et al. Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 387, n. 6, p. 591-598, 2014Tradução . . Disponível em: https://doi.org/10.1007/s00210-014-0970-8. Acesso em: 01 maio 2024. -
APA
Montenegro, M. F., Pinheiro, L. C., Amaral, J. H., Ferreira, G. C., Portella, R. L., & Tanus-Santos, J. E. (2014). Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension. Naunyn-Schmiedeberg's Archives of Pharmacology, 387( 6), 591-598. doi:10.1007/s00210-014-0970-8 -
NLM
Montenegro MF, Pinheiro LC, Amaral JH, Ferreira GC, Portella RL, Tanus-Santos JE. Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2014 ; 387( 6): 591-598.[citado 2024 maio 01 ] Available from: https://doi.org/10.1007/s00210-014-0970-8 -
Vancouver
Montenegro MF, Pinheiro LC, Amaral JH, Ferreira GC, Portella RL, Tanus-Santos JE. Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2014 ; 387( 6): 591-598.[citado 2024 maio 01 ] Available from: https://doi.org/10.1007/s00210-014-0970-8 - Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Sequence diversity and functional charactterization of the 5´-regulatory region of human cyp2c19
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Hemodynamic effects of bupropion in anesthetized dogs
- Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity
Informações sobre o DOI: 10.1007/s00210-014-0970-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas